False Memory and Alzheimer's Disease Pathology in Patients with Amnestic Mild Cognitive Impairment: A Study with...

Area of Science:

• Neuroscience
• Cognitive Psychology
• Medical Diagnostics

Background:

• False memory, characterized by intrusion errors or false positives (FPs), is common in Alzheimer's disease (AD).
• Investigation into FPs in amnestic mild cognitive impairment (a-MCI) with Alzheimer's disease pathology (ADP) is limited.
• This study examines false versus veridical memory in a-MCI patients to assess FP utility for ADP discrimination.

Purpose of the Study:

• To analyze false and true memory performance in individuals with a-MCI.
• To determine if false memory can effectively discriminate between a-MCI patients with and without Alzheimer's disease pathology (ADP).
• To evaluate the diagnostic accuracy of false memory for identifying ADP.

Main Methods:

• Patients with a-MCI were assessed using neuropsychological testing and amyloid PET scans to categorize them into "with ADP" and "without ADP" groups.
• Memory tests were administered to evaluate both veridical (true) and false memory recall.
• Logistic regression and receiver-operating characteristic (ROC) curve analysis were employed to assess the discriminatory power of false memory for ADP.

Main Results:

• The group with ADP exhibited significantly more FPs and lower response verity across delayed memory tests compared to the non-ADP group.
• No significant differences in veridical memory performance were found between the groups.
• Increased FPs were associated with a 1.31-1.36 times higher risk of ADP, with low to moderate discriminatory accuracy.

Conclusions:

• Elevated false memory, specifically FPs, emerged as a key indicator for differentiating ADP from non-ADP in a-MCI patients.
• Further research into the mechanisms of false memory is crucial for understanding its role in Alzheimer's disease progression.
• False memory performance shows potential as a biomarker for early Alzheimer's detection in a-MCI.